To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Smith is expected to start the role on Wednesday and would also serve as a board member, the government-backed mortgage provider said. ...

It's time for me to update my thesis on Safran SA ( SAFRY ). This is unfortunately one of those companies where I went "Hold" too early. Remember, however, that I rated Safran a "Buy" long before it went here. So, evenAnalyst’s Disclosure:I/we have a beneficial long position in the shares of EADSY either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no busin ...

Kevin Hassett and Kevin Warsh are in a neck-and-neck race for the next chairman of the Federal Reserve – with the lead changing hands on prediction markets several times this week.Hassett, director of the National Economic Council, regained the top spot on Kalshi and Polymarket on Tuesday as he pleaded his case for the job.The Fed’s “independence is really, really important, and the voices of the other people at the [Federal Open Market Committee], they’re important, too,” Hassett told CNBC on Tuesday.Kevin ...

Monte Rosa Therapeutics Inc. (NASDAQ:GLUE) shared interim data from an ongoing Phase 1/2 clinical study evaluating MRT-2359 in combination with enzalutamide in heavily pretreated patients with metastatic castration-resistant prostate cancer (mCRPC).The Phase 1/2 study evaluated 0.5 mg and 0.75 mg of MRT-2359 administered orally on a 21-days-on, 7-day-off drug schedule in combination with Pfizer Inc. (NYSE:PFE) and Astellas Pharma Inc.’s (OTC:ALPMF) (OTC:ALPMY) Xtandi (enzalutamide).The study population, as ...

Robot ETFs can electrify your portfolio's gains thanks to their focus on AI chipmakers and physical AI opportunities.Artificial intelligence (AI) has been the defining trend for the stock market. Some AI stocks have rocketed tenfold within five years, and AI exchange-traded funds (ETFs) have been some of the market's top-performing funds.However, the next big winners may be robot stocks and ETFs. These funds also ride AI tailwinds but focus on physical AI. Humanoid robots, drones, and AI-powered surgical to ...

To see all that our exclusive membership has to offer, sign up for a free trial by clicking on the button below!At the CEF/ETF Income Laboratory , we manage closed-end fund ("CEF") and exchange-traded fund ("ETF") portfolios targeting safe and reliable ~8% yields to make income investing easy for you. Check out what our members have to say about our service.ArrowMark Financial Corp. ( BANX ) has continued to perform well since our last update, when we were going through the April tariff announcement volatil ...

About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...

It's time now for the 360 round. For that, let's bring in our panel to discuss the outlook for AI in 2026. Joining us now, Noah Hammond, CEO of Advisor Shares, and Daniel Rubino, the editor-inchief at Windows Central.You know, Daniel, I'd love to start with you. You know, we had AI in 2025 seemingly focused on building capac uh capability. You know, what is 2026 really about.Is it scale now. Is it monetization. Or is it consolidation.>> H great question. And so there's a lot going on here, right. The issue ...

Year-end trading on Wall Street follows a familiar pattern, and the same question resurfaces once again: will the Santa Claus rally make an appearance?The stretch between Christmas and the first trading days of January is historically known for the Santa Claus rally, a period when stocks have typically pushed higher amid lighter volumes, tax-driven trades and year-end optimism.It's a pattern that's been debated, dismissed, and rediscovered for decades, yet the numbers keep pulling investors back in.S&P 500' ...